search
Back to results

Transversalis Fascial Plane Nerve Block in Iliac Crest Bone Graft

Primary Purpose

Upper Limb Surgery, Iliac Crest Bone Harvest

Status
Completed
Phase
Not Applicable
Locations
Canada
Study Type
Interventional
Intervention
Active treatment
Placebo Arm
Sponsored by
University Health Network, Toronto
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Upper Limb Surgery focused on measuring supraclavicular nerve block, regional anesthesia, transversalis fascia plane block, ultrasound guided, opioid consumption, iliac crest bone harvest, hand surgery, wrist surgery, Upper limb surgery combined with iliac crest bone harvest.

Eligibility Criteria

18 Years - 85 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  1. ASA physical status I-III
  2. 18-85 years of age, inclusive
  3. Weight 50kg+
  4. Scheduled for elective upper limb surgery, which can be solely performed under a brachial plexus block, and requiring an ICBG

Exclusion Criteria:

  1. Contraindications to regional blockade (e.g., allergy to local anesthetics, coagulopathy, malignancy or infection in the area)
  2. Pregnancy
  3. History of alcohol or drug dependency/abuse
  4. History of long term opioid intake or chronic pain disorder
  5. History of significant psychiatric conditions that may affect patient assessment
  6. Failure of upper extremity block
  7. Previous iliac crest bone grafting
  8. History of severe pelvic and hip conditions that could interfere with the long-term functional assessments of the study
  9. Inability to understand the informed consent and demands of the study.

Sites / Locations

  • Toronto Western Hospital

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Placebo Comparator

Arm Label

Active treatment group

Placebo arm

Arm Description

Ultrasound-guided TFP block with 20ml 0.5% ropivacaine + 1:200 000 epinephrine

Ultrasound-guided TFP block with 20ml of 5% dextrose solution

Outcomes

Primary Outcome Measures

Opioid consumption
Opioid consumption in the first 24 hours following ICBG. This will be expressed in terms of milligrams doses of IV morphine. Where other opioids are used, the doses will be converted to the equivalent IV morphine dose using standard opioid dosage conversion tables.

Secondary Outcome Measures

Opioid consumption
Opioid consumption (expressed as milligram doses of IV morphine) in the following phases Intraoperative phase (from start of surgery to end of surgery) Postoperative care unit stay (from admission to discharge) First 48 hours following ICBG
Pain measures
Pain scores at the ICBG site, measured using a visual analogue scale (VAS) (scale 0-10) and starting in recovery, then every 4 hrs for the next 48 hrs. Pain at the primary surgical site (VAS 0-10) Duration of block, defined as the time from completion of block performance to the time of onset of increased pain at the ICBG harvest site (as perceived by the patient)
Time of block performance
Time required to perform the TFP block (defined as the time between placement of the ultrasound probe on the patient, and withdrawal of the block needle)
Complications
TFP block complications and adverse events (e.g. vascular puncture, intravascular local anesthetic injection and local hematoma)

Full Information

First Posted
May 27, 2010
Last Updated
December 13, 2017
Sponsor
University Health Network, Toronto
search

1. Study Identification

Unique Protocol Identification Number
NCT01133730
Brief Title
Transversalis Fascial Plane Nerve Block in Iliac Crest Bone Graft
Official Title
The Analgesic Efficacy of the Transversalis Fascia Plane Block in Iliac Crest Bone Graft Harvesting
Study Type
Interventional

2. Study Status

Record Verification Date
May 2010
Overall Recruitment Status
Completed
Study Start Date
August 2010 (Actual)
Primary Completion Date
June 2012 (Actual)
Study Completion Date
December 2012 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University Health Network, Toronto

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
Hand or wrist surgery often requires the use of bony material in order to accomplish any associated reconstructive aspects required for the surgery. The iliac crest is often used as the source of bone for such surgery and harvesting from this site is performed simultaneously with the hand/wrist surgery. In terms of anesthesia, patients typically receive a supraclavicular nerve block for the hand/wrist surgery, and a general anesthestic for the bone graft, though spinal block may also be performed. This study will look at the use of a transversalis fascia plane (TFP) nerve block (ie, to numb the nerves going to the iliac crest) in combination with a general anesthetic to see if post-operative pain and opioid consumption is reduced using the TFP block.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Upper Limb Surgery, Iliac Crest Bone Harvest
Keywords
supraclavicular nerve block, regional anesthesia, transversalis fascia plane block, ultrasound guided, opioid consumption, iliac crest bone harvest, hand surgery, wrist surgery, Upper limb surgery combined with iliac crest bone harvest.

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
56 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Active treatment group
Arm Type
Experimental
Arm Description
Ultrasound-guided TFP block with 20ml 0.5% ropivacaine + 1:200 000 epinephrine
Arm Title
Placebo arm
Arm Type
Placebo Comparator
Arm Description
Ultrasound-guided TFP block with 20ml of 5% dextrose solution
Intervention Type
Drug
Intervention Name(s)
Active treatment
Intervention Description
US-guided TFP block with 20ml 0.5% ropivacaine + 1:200 000 epinephrine
Intervention Type
Drug
Intervention Name(s)
Placebo Arm
Intervention Description
US-guided TFP block with 20ml of 5% dextrose solution
Primary Outcome Measure Information:
Title
Opioid consumption
Description
Opioid consumption in the first 24 hours following ICBG. This will be expressed in terms of milligrams doses of IV morphine. Where other opioids are used, the doses will be converted to the equivalent IV morphine dose using standard opioid dosage conversion tables.
Time Frame
24 hours
Secondary Outcome Measure Information:
Title
Opioid consumption
Description
Opioid consumption (expressed as milligram doses of IV morphine) in the following phases Intraoperative phase (from start of surgery to end of surgery) Postoperative care unit stay (from admission to discharge) First 48 hours following ICBG
Time Frame
7 days
Title
Pain measures
Description
Pain scores at the ICBG site, measured using a visual analogue scale (VAS) (scale 0-10) and starting in recovery, then every 4 hrs for the next 48 hrs. Pain at the primary surgical site (VAS 0-10) Duration of block, defined as the time from completion of block performance to the time of onset of increased pain at the ICBG harvest site (as perceived by the patient)
Time Frame
48 hours
Title
Time of block performance
Description
Time required to perform the TFP block (defined as the time between placement of the ultrasound probe on the patient, and withdrawal of the block needle)
Time Frame
6 hours
Title
Complications
Description
TFP block complications and adverse events (e.g. vascular puncture, intravascular local anesthetic injection and local hematoma)
Time Frame
12 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
85 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: ASA physical status I-III 18-85 years of age, inclusive Weight 50kg+ Scheduled for elective upper limb surgery, which can be solely performed under a brachial plexus block, and requiring an ICBG Exclusion Criteria: Contraindications to regional blockade (e.g., allergy to local anesthetics, coagulopathy, malignancy or infection in the area) Pregnancy History of alcohol or drug dependency/abuse History of long term opioid intake or chronic pain disorder History of significant psychiatric conditions that may affect patient assessment Failure of upper extremity block Previous iliac crest bone grafting History of severe pelvic and hip conditions that could interfere with the long-term functional assessments of the study Inability to understand the informed consent and demands of the study.
Facility Information:
Facility Name
Toronto Western Hospital
City
Toronto
State/Province
Ontario
ZIP/Postal Code
M5T 2S8
Country
Canada

12. IPD Sharing Statement

Learn more about this trial

Transversalis Fascial Plane Nerve Block in Iliac Crest Bone Graft

We'll reach out to this number within 24 hrs